SPAC Presentation

1 Organic Growth: B2B & B2C Segments Clear Strategy to Propel Strong Organic Growth in a Diversified Portfolio Main Avenues of Growth B2B Segment ■ Increase market share with current multinational clients I ■ I B2C Segment ■ ■ ■ I Capture new customers Commercialization of new proprietary formulations Develop new patented technologies ■ Growth from existing portfolio New products on current therapeutic areas Roll-out of successful products in Colombia to other countries Enter new therapeutic areas Expansion into new markets Source: Procaps Note: (1) Products launched within the last 36 months New Product Launches B2B CDMO Services B2C Rx Drugs OTC Products Diabetes Solutions Softi Sel IPROCAS FARMA PROCAPS CLINICAL SPECIALTIES VitalCare DIABETRICS 361 EN FUNCION DE LA VIDA Number of Products 2021E2023E 52 402 51 90 28 2021E Sales Forecast from New Product Launches¹ (USD mm) 44.0 23.7 10.9 6.8 6.1 2022E 50.6 34.6 8.5 9.4 PROCAPS 8.1 2023E 57.2 49.0 6.3 11.8 GROUP 9.5 * 33

View entire presentation